Artículos por temáticas

The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence

Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJ, Rozemuller AJ, van Gool WA.

Curr Alzheimer Res. 2011 Mar;8(2):142-50. doi: 10.2174/156720511795256080.

Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease

Proctor DT, Coulson EJ, Dodd PR.

Prog Neurobiol. 2011 Apr;93(4):509-21. doi: 10.1016/j.pneurobio.2011.02.002. Epub 2011 Mar 4.

Mechanisms of neural and behavioral dysfunction in Alzheimer's disease

Wesson DW, Nixon RA, Levy E, Wilson DA.

Mol Neurobiol. 2011 Jun;43(3):163-79. doi: 10.1007/s12035-011-8177-1. Epub 2011 Mar 22.

The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease

Leoni V.

Clin Chem Lab Med. 2011 Mar;49(3):375-83. doi: 10.1515/CCLM.2011.088.

Effects of attention on dichotic listening in elderly and patients with dementia of the Alzheimer type

Bouma A, Gootjes L.

Brain Cogn. 2011 Jul;76(2):286-93. doi: 10.1016/j.bandc.2011.02.008. Epub 2011 Mar 22.

Amyloid-dependent and amyloid-independent stages of Alzheimer disease

Hyman BT.

Arch Neurol. 2011 Aug;68(8):1062-4. doi: 10.1001/archneurol.2011.70. Epub 2011 Apr 11.

Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide

Armstrong AH, Chen J, McKoy AF, Hecht MH.

Biochemistry. 2011 May 17;50(19):4058-67. doi: 10.1021/bi200268w. Epub 2011 Apr 22.

Cerebral microbleeds on MR imaging: comparison between 1.5 and 7T

Conijn MM, Geerlings MI, Biessels GJ, Takahara T, Witkamp TD, Zwanenburg JJ, Luijten PR, Hendrikse J.

AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1043-9. doi: 10.3174/ajnr.A2450. Epub 2011 May 5.

Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein

Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, Walsh DM, Rowan MJ.

J Neurosci. 2011 May 18;31(20):7259-63. doi: 10.1523/JNEUROSCI.6500-10.2011.

A comparison of voxel and surface based cortical thickness estimation methods

Clarkson MJ, Cardoso MJ, Ridgway GR, Modat M, Leung KK, Rohrer JD, Fox NC, Ourselin S.

Neuroimage. 2011 Aug 1;57(3):856-65. doi: 10.1016/j.neuroimage.2011.05.053. Epub 2011 May 26.

Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene

Marcon G, Rossi G, Giaccone G, Giovagnoli AR, Piccoli E, Zanini S, Geatti O, Toso V, Grisoli M, Tagliavini F.

J Alzheimers Dis. 2011;26(3):583-90. doi: 10.3233/JAD-2011-110332.

4 new genes identified as raising Alzheimer's disease risk. A multi-center research project unveils more targets to study for potential future treatment

Duke Med Health News. 2011 Jun;17(6):4-5.

Risk factors for Alzheimer disease: aging beyond age?

Dartigues JF, Féart C.

Neurology. 2011 Jul 19;77(3):206-7. doi: 10.1212/WNL.0b013e31822550af. Epub 2011 Jul 13.

Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease

Antúnez C, Boada M, López-Arrieta J, Moreno-Rey C, Hernández I, Marín J, Gayán J; Alzheimer's Disease Neuroimaging Initiative; González-Pérez A, Real LM, Alegret M, Tárraga L, Ramírez-Lorca R, Ruiz A.

Alzheimers Dement. 2011 Jul;7(4):e124-9. doi: 10.1016/j.jalz.2011.05.2412.

[Serum anticholinergic activity: relationship with clinical symptoms in Alzheimer's disease and proposal of new biological marker]

Hori K, Konishi K, Hachisu M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Jun;31(3):135-40.